Artwork
iconShare
 
Manage episode 497282044 series 3667451
Content provided by MEDVACON Life Sciences. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by MEDVACON Life Sciences or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Send us a text

In pharmaceutical and biotech manufacturing, artificial intelligence is no longer a future concept. It’s here, supporting product development, process control, and quality decisions in GMP-regulated environments. But with this opportunity comes significant responsibility. While AI offers powerful capabilities, it also introduces a new set of risks, ones that must be managed to meet compliance, safety, and quality expectations.

In this Quality Grind Short - Mike outlines both the risks and opportunities that AI provides, and highlights guidance being provided by global regulatory agencies.

Contact MEDVACON:

Thanks for listening! Don't forget to follow us @medvacon on all platforms for updates on blogs and podcasts!

  continue reading

40 episodes